FindTrial
Sign In

Treatment of Gingival Recession Using Mesenchymal Stem Cells

Treatment of Gingival Recession Using Autologous Adipose-derived Mesenchymal Stem Cells

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04434794
Enrollment
27
Registered
2020-06-17
Start date
2018-01-01
Completion date
2019-12-31
Last updated
2020-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival Recession

Keywords

Gingival Recession

Brief summary

Treatment of patients with gingival recession by injection of autologous adipose-derived mesenchymal stem cells mixed with collagen gel

Detailed description

Treatment of patients with gingival recession by injection of autologous adipose-derived mesenchymal stem cells mixed with collagen gel (1×106cells/0.2 ml). The volume of the mixture is divided into 4 equal injections in the gingival region of one tooth (one place injection volume is 0.05 ml of mixture).

Interventions

OTHERstandard treatment

standard treatment according to clinical protocols

BIOLOGICALmesenchymal stem cells

autologous mesenchymal stem cells

Sponsors

Belarusian Medical Academy of Post-Graduate Education
CollaboratorOTHER
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

-gingival recession

Exclusion criteria

* pregnancy * breast-feeding * acute and chronic infectious diseases: HIV, viral hepatitis, tuberculosis * mental disorders

Design outcomes

Primary

MeasureTime frameDescription
number of patients cured1 monthnumber of patients cured

Countries

Belarus

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026